Open Access
Open access
volume 14 issue 12 pages 1229

Novel Aminoguanidine Hydrazone Analogues: From Potential Antimicrobial Agents to Potent Cholinesterase Inhibitors

Martin Krátký 1
Šárka Štěpánková 2
Klára Konečná 3
Katarína Svrčková 2
Jana Maixnerová 4
Markéta Švarcová 1, 5
Ondřej Janďourek 3
František Trejtnar 4
Jarmila Vinšová 1
Publication typeJournal Article
Publication date2021-11-26
scimago Q1
wos Q1
SJR1.019
CiteScore7.7
Impact factor4.8
ISSN14248247
PubMed ID:  34959630
Drug Discovery
Pharmaceutical Science
Molecular Medicine
Abstract

A series of thirty-one hydrazones of aminoguanidine, nitroaminoguanidine, 1,3-diaminoguanidine, and (thio)semicarbazide were prepared from various aldehydes, mainly chlorobenzaldehydes, halogenated salicylaldehydes, 5-nitrofurfural, and isatin (yields of 50–99%). They were characterized by spectral methods. Primarily, they were designed and evaluated as potential broad-spectrum antimicrobial agents. The compounds were effective against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus with minimum inhibitory concentrations (MIC) from 7.8 µM, as well as Gram-negative strains with higher MIC. Antifungal evaluation against yeasts and Trichophyton mentagrophytes found MIC from 62.5 µM. We also evaluated inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The compounds inhibited both enzymes with IC50 values of 17.95–54.93 µM for AChE and ≥1.69 µM for BuChE. Based on the substitution, it is possible to modify selectivity for a particular cholinesterase as we obtained selective inhibitors of either AChE or BuChE, as well as balanced inhibitors. The compounds act via mixed-type inhibition. Their interactions with enzymes were studied by molecular docking. Cytotoxicity was assessed in HepG2 cells. The hydrazones differ in their toxicity (IC50 from 5.27 to >500 µM). Some of the derivatives represent promising hits for further development. Based on the substitution pattern, it is possible to modulate bioactivity to the desired one.

Found 
Found 

Top-30

Journals

1
2
Journal of Molecular Structure
2 publications, 11.76%
European Journal of Medicinal Chemistry
2 publications, 11.76%
Antibiotics
1 publication, 5.88%
Frontiers in Chemistry
1 publication, 5.88%
Pharmaceuticals
1 publication, 5.88%
Fundamental and Clinical Pharmacology
1 publication, 5.88%
Mendeleev Communications
1 publication, 5.88%
Journal of Enzyme Inhibition and Medicinal Chemistry
1 publication, 5.88%
Brazilian Journal of Microbiology
1 publication, 5.88%
International Journal of Molecular Sciences
1 publication, 5.88%
Chemico-Biological Interactions
1 publication, 5.88%
ACS Chemical Neuroscience
1 publication, 5.88%
Biochemistry and Biophysics Reports
1 publication, 5.88%
RSC Advances
1 publication, 5.88%
1
2

Publishers

1
2
3
4
5
6
Elsevier
6 publications, 35.29%
MDPI
3 publications, 17.65%
Frontiers Media S.A.
1 publication, 5.88%
Wiley
1 publication, 5.88%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 5.88%
Taylor & Francis
1 publication, 5.88%
Cold Spring Harbor Laboratory
1 publication, 5.88%
Springer Nature
1 publication, 5.88%
American Chemical Society (ACS)
1 publication, 5.88%
Royal Society of Chemistry (RSC)
1 publication, 5.88%
1
2
3
4
5
6
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
17
Share
Cite this
GOST |
Cite this
GOST Copy
Krátký M. et al. Novel Aminoguanidine Hydrazone Analogues: From Potential Antimicrobial Agents to Potent Cholinesterase Inhibitors // Pharmaceuticals. 2021. Vol. 14. No. 12. p. 1229.
GOST all authors (up to 50) Copy
Krátký M., Štěpánková Š., Konečná K., Svrčková K., Maixnerová J., Švarcová M., Janďourek O., Trejtnar F., Vinšová J. Novel Aminoguanidine Hydrazone Analogues: From Potential Antimicrobial Agents to Potent Cholinesterase Inhibitors // Pharmaceuticals. 2021. Vol. 14. No. 12. p. 1229.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/ph14121229
UR - https://doi.org/10.3390/ph14121229
TI - Novel Aminoguanidine Hydrazone Analogues: From Potential Antimicrobial Agents to Potent Cholinesterase Inhibitors
T2 - Pharmaceuticals
AU - Krátký, Martin
AU - Štěpánková, Šárka
AU - Konečná, Klára
AU - Svrčková, Katarína
AU - Maixnerová, Jana
AU - Švarcová, Markéta
AU - Janďourek, Ondřej
AU - Trejtnar, František
AU - Vinšová, Jarmila
PY - 2021
DA - 2021/11/26
PB - MDPI
SP - 1229
IS - 12
VL - 14
PMID - 34959630
SN - 1424-8247
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2021_Krátký,
author = {Martin Krátký and Šárka Štěpánková and Klára Konečná and Katarína Svrčková and Jana Maixnerová and Markéta Švarcová and Ondřej Janďourek and František Trejtnar and Jarmila Vinšová},
title = {Novel Aminoguanidine Hydrazone Analogues: From Potential Antimicrobial Agents to Potent Cholinesterase Inhibitors},
journal = {Pharmaceuticals},
year = {2021},
volume = {14},
publisher = {MDPI},
month = {nov},
url = {https://doi.org/10.3390/ph14121229},
number = {12},
pages = {1229},
doi = {10.3390/ph14121229}
}
MLA
Cite this
MLA Copy
Krátký, Martin, et al. “Novel Aminoguanidine Hydrazone Analogues: From Potential Antimicrobial Agents to Potent Cholinesterase Inhibitors.” Pharmaceuticals, vol. 14, no. 12, Nov. 2021, p. 1229. https://doi.org/10.3390/ph14121229.